I

Intervacc AB

12 employees

Intervacc is a biotechnology company that develops vaccines based on recombinant proteins for animal health.

Basic info

pharmaceutical manufacturing

Biotechnology

Pharmaceutical

Veterinary

Vaccines

Biotech

Recombinant Vaccines

Animal Health

Health Care

Veterinary Products

Research and Development

Wholesale

Microbiology

2001

$4.4M

from 1 investors over 1 rounds

I

Intervacc AB raised $4.4M on December 20, 2010

Investors: Knutsson Holdings AB